본문 바로가기
KERD
논문KCI 등재

대한갑상선학회 갑상선분화암 진료권고안; Part III. 진행성 갑상선분화암의 치료 - 제1-2장 갑상선 수술부위 재발 또는 경부 전이림프절에 대한 수술 및 비수술적 치료 2024

Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 1-2. Locally Recurred/Persistent Thyroid Cancer Management Strategies 2024

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

These guidelines aim to establish the standard practice for diagnosing and treating patients with differentiated thyroid cancer (DTC). Based on the Korean Thyroid Association (KTA) Guidelines on DTC management, the “Treatment of Advanced DTC” section was revised in 2024 and has been provided through this chapter. Especially, this chapter covers surgical and nonsurgical treatments for the local (previous surgery site) or regional (cervical lymph node metastasis) recurrences. After drafting the guidelines, it was finalized by collecting opinions from KTA members and related societies. Surgical resection is the preferred treatment for local or regional recurrence of advanced DTC. If surgical resection is not possible, nonsurgical resection treatment under ultrasonography guidance may be considered as an alternative treatment for local or regional recurrence of DTC. Furthermore, if residual lesions are suspected even after surgical resection or respiratory-digestive organ invasion, additional radioactive iodine and external radiation treatments are considered.

Abstract

These guidelines aim to establish the standard practice for diagnosing and treating patients with differentiated thyroid cancer (DTC). Based on the Korean Thyroid Association (KTA) Guidelines on DTC management, the “Treatment of Advanced DTC” section was revised in 2024 and has been provided through this chapter. Especially, this chapter covers surgical and nonsurgical treatments for the local (previous surgery site) or regional (cervical lymph node metastasis) recurrences. After drafting the guidelines, it was finalized by collecting opinions from KTA members and related societies. Surgical resection is the preferred treatment for local or regional recurrence of advanced DTC. If surgical resection is not possible, nonsurgical resection treatment under ultrasonography guidance may be considered as an alternative treatment for local or regional recurrence of DTC. Furthermore, if residual lesions are suspected even after surgical resection or respiratory-digestive organ invasion, additional radioactive iodine and external radiation treatments are considered.

참고문헌 (38)

  1. Mazzaferri EL, "An overview of the management of papillary and follicular thyroid carcinoma", Thyroid, 9(5), pp.421~427 (1999)
  2. Mazzaferri EL, "Long-term outcome of patients with differentiated thyroid carcinoma : effect of therapy", Endocr Pract, 6(6), pp.469~476 (2000)
  3. Cooper DS, "Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer : results from the National Thyroid Cancer Treatment Cooperative Registry", Thyroid, 8(9), pp.737~744 (1998)
  4. Clayman GL, "Long-term outcome of comprehensive central compartment dissection in patients with recurrent", persistent papillary thyroid carcinoma, 2011, pp.21(12), 1309~1316
  5. Lin JD, "Use of radioactive iodine for thyroid remnant ablation in welldifferentiated thyroid carcinoma to replace thyroid reoperation", Am J Clin Oncol, 21(1), pp.77~81 (1998)
  6. Chinn SB, "Long-term outcomes of lateral neck dissection in patients with recurrent or persistent welldifferentiated thyroid cancer", Thyroid, 27(10), pp.1291~1299 (2017)
  7. Brierley JD, "A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example", Cancer, 79(12), pp.2414~2423 (1997)
  8. Hay ID, "Papillary thyroid carcinoma managed at the Mayo Clinic during six decades(1940-1999) : temporal trends in initial therapy and long-term outcome in 2444consecutively treated patients", World J Surg, 26(8), pp.879~885 (2002)
  9. Ge JH, "Surgical treatment of advanced thyroid carcinoma with aero-digestive invasion", Zhonghua Er Bi Yan Hou Ke Za Zhi, 39(4), pp.237~240 (2004)
  10. Avenia N, "Locally advanced thyroid cancer : therapeutic options", Chir Ital, 56(4), pp.501~508 (2004)
  11. Van Nostrand D, "The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer", Thyroid, 19(12), pp.1381~1391 (2009)
  12. Haymart MR, "Disease severity and radioactive iodine use for thyroid cancer", J Clin Endocrinol Metab, 98(2), pp.678~686 (2013)
  13. McCaffrey JC, "Evaluation and treatment of aerodigestive tract invasion by well-differentiated thyroid carcinoma", Cancer Control, 7(3), pp.246~252 (2000)
  14. Musholt TJ, "Invasive differentiated thyroid carcinoma : tracheal resection and reconstruction procedures in the hands of the endocrine surgeon", Surgery, 126(6), pp.1078~1087 (1999)
  15. Czaja JM, "The surgical management of laryngotracheal invasion by well-differentiated papillary thyroid carcinoma", Arch Otolaryngol Head Neck Surg, 123(5), pp.484~490 (1997)
  16. Shindo ML, "Management of invasive well-differentiated thyroid cancer : an American Head and Neck Society consensus statement. AHNS consensus statement", Head Neck, 36(10), pp.1379~1390 (2014)
  17. Cabanillas ME, "Thyroid cancer", Lancet, 388(10061), pp.2783~2795 (2016)
  18. Medas F, "Complications after reoperative thyroid surgery : retrospective evaluation of 152 consecutive cases", Updates Surg, 71(4), pp.705~710 (2019)
  19. Kim JH, "2017 thyroid radiofrequency ablation guideline : Korean Society of Thyroid Radiology", Korean J Radiol, 19(4), pp.632~655 (2018)
  20. Mauri G, "European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the use of minimally invasive treatments in malignant thyroid lesions", Eur Thyroid J, 10(3), pp.185~197 (2021)
  21. Orloff LA, "Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease : an international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association", Head Neck, 44(3), pp.633~660 (2022)
  22. Kim SY, "Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer", Eur Arch Otorhinolaryngol, 274(9), pp.3497~3501 (2017)
  23. Zhang X, "Ultrasonography-guided thermal ablation for cervical lymph node metastasis of recurrent papillary thyroid carcinoma : is it superior to surgical resection?", Front Endocrinol(Lausanne), 13, pp.907195~ (2022)
  24. Dupuy DE, "Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy", Surgery, 130(6), pp.971~977 (2001)
  25. Park KW, "Inoperable symptomatic recurrent thyroid cancers : preliminary result of radiofrequency ablation", Ann Surg Oncol, 18(9), pp.2564~2568 (2011)
  26. Baek JH, "Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation", AJR Am J Roentgenol, 197(2), pp.W331~W336 (2011)
  27. Lee SJ, "Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma", Korean J Radiol, 15(6), pp.817~826 (2014)
  28. Wang L, "Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma", J Cancer Res Ther, 10(Suppl), pp.C144~C149 (2014)
  29. Kim JH, "Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm", Radiology, 276(3), pp.909~918 (2015)
  30. Lim HK, "Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer", Eur Radiol, 25(1), pp.163~170 (2015)
  31. Choi Y, "Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers : a single-center propensity score matching study", Int J Hyperthermia, 36(1), pp.359~367 (2019)
  32. Tang W, "Evaluating the safety and efficacy of microwave ablation in treatment of cervical metastatic lymph nodes of papillary thyroid carcinoma compared to repeat surgery", Int J Hyperthermia, 39(1), pp.813~821 (2022)
  33. Urken ML, "Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer : a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative", Head Neck, 37(4), pp.605~614 (2015)
  34. Ding Z, "Efficacy and safety of thermal ablation for treating lymph node metastasis from papillary thyroid carcinoma : a systematic review and meta-analysis", Front Oncol, 12, pp.738299~ (2022)
  35. Suh CH, "Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer : a systematic review and meta-analysis", Thyroid, 26(3), pp.420~428 (2016)
  36. Chung SR, "Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer", Eur Radiol, 29(9), pp.4897~4903 (2019)
  37. Chung SR, "Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers : a systematic review and meta-analysis", Int J Hyperthermia, 33(8), pp.920~930 (2017)
  38. Kim C, "Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers", Eur Radiol, 27(8), pp.3128~3137 (2017)

관련 논문AI추천

대한갑상선학회 갑상선분화암 진료권고안 2024 어떻게 바뀌었나: 진단부터 초기치료까지이은경대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제2호대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제7장 갑상선분화암에서 수술 후 추가적인 외부 방사선조사나 항암 치료의 역할 2024강호철, 김선욱, 김원구, 나동규, 문신제, 박영주, 송영신, 신동엽, 이은경, 임동준, 정윤재대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안; Part II. 갑상선분화암의 추적 2024강호철, 김미진, 김보현, 김선욱, 나동규, 박영주, 방지인, 서영덕, 송영신, 오소원, 이민경, 이상우, 이은경, 이지예, 임동준, 정아리, 정윤재, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안; Part III. 진행성 갑상선분화암의 치료 - 제4장 진행성 방사성요오드 불응성 갑상선분화암의 전신항암치료 2024강호철, 김선욱, 김원구, 나동규, 박영주, 송영신, 신동엽, 이은경, 임동준, 정윤재대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제6장 갑상선분화암의 갑상선절제술 후 방사성요오드 치료 2024강호철, 김근영, 김선욱, 나동규, 박소현, 박영주, 방지인, 서영덕, 송영신, 오소원, 이상우, 이은경, 임동준, 정아리, 정윤재, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024강호철, 구본석, 권형주, 김근영, 김미진, 김보현, 김선욱, 김원구, 김원배, 김원웅, 김정한, 김희경, 나동규, 나희영, 문신제, 문정은, 박도준, 박소현, 박영주, 박준욱, 방지인, 백교림, 서영덕, 송영신, 신동엽, 신수진, 안화영, 오소원, 우승훈, 원호륜, 유창환, 윤지희, 이가희, 이민경, 이상우, 이승은, 이시훈, 이영아, 이은경, 이준협, 이지예, 이지은, 이초록, 임동준, 임재열, 전윤경, 정경연, 정아리, 정웅윤, 정윤재, 정찬권, 조관훈, 조윤영, 홍아람, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호

이 간행물의 다른 논문 (16건)

대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024조윤영, 이승은, 박소현, 이상우, 이준협, 이지예, 이지은, 김희경, 이은경, 이민경, 김미진, 김선욱, 김정한, 정경연, 강호철, 임동준, 서영덕, 김원구, 이시훈, 문정은, 신수진, 김원배, 윤지희, 오소원, 송영신, 이가희, 임재열, 전윤경, 신동엽, 정윤재, 나동규, 김근영, 이영아, 김보현, 방지인, 조관훈, 박영주, 홍채문, 문신제, 홍아람, 백교림, 정웅윤, 정아리, 원호륜, 권형주, 나희영, 이초록, 우승훈, 박도준, 유창환, 정찬권, 박준욱, 김원웅, 구본석, 안화영pp. 1-20대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제1장 갑상선분화암의 수술 전 병기를 예측하기 위한 영상 및 혈액 검사 2024김선욱, 이민경, 박영주, 이은경, 이상우, 나동규, 정윤재, 송영신, 임동준, 강호철, 이지예, 조관훈, 방지인pp. 21-29대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제2장 갑상선분화암의 적절한 초기 수술 2024조윤영, 김정한, 김선욱, 이민경, 박영주, 이은경, 김희경, 이지예, 이준협, 나동규, 정윤재, 임재열, 송영신, 윤지희, 임동준, 강호철, 구본석, 김원웅, 박준욱, 정찬권, 유창환, 우승훈, 이초록, 권형주, 원호륜, 백교림pp. 30-52대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제3장 갑상선분화암의 수술 전후 합병증 평가 2024김선욱, 박영주, 이시훈, 유창환, 홍아람, 원호륜, 우승훈, 박준욱, 구본석, 강호철, 임동준, 이은경, 나동규, 정윤재, 전윤경, 임재열, 송영신pp. 53-60대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제4장 갑상선분화암의 수술 후 병리학적 진단 및 병기 결정 2024김선욱, 신수진, 나희영, 정찬권, 강호철, 임동준, 송영신, 정윤재, 나동규, 이은경, 박영주pp. 61-67